Genfit Future Growth
Future criteria checks 5/6
Genfit is forecast to grow earnings and revenue by 52.3% and 23.8% per annum respectively while EPS is expected to grow by 53.1% per annum.
Key information
52.3%
Earnings growth rate
53.1%
EPS growth rate
Biotechs earnings growth | 31.1% |
Revenue growth rate | 23.8% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 13 Feb 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 64 | 9 | N/A | N/A | 3 |
12/31/2025 | 49 | -19 | -14 | -22 | 5 |
12/31/2024 | 85 | 24 | -26 | -27 | 6 |
12/31/2023 | 62 | 4 | -26 | -26 | 6 |
6/30/2023 | 29 | -34 | -52 | -50 | N/A |
3/31/2023 | 28 | -29 | -62 | -61 | N/A |
12/31/2022 | 26 | -24 | -73 | -73 | N/A |
9/30/2022 | 60 | 12 | 4 | 4 | N/A |
6/30/2022 | 94 | 48 | 80 | 80 | N/A |
3/31/2022 | 90 | 58 | 90 | 90 | N/A |
12/31/2021 | 85 | 67 | 99 | 100 | N/A |
9/30/2021 | 46 | 14 | 10 | 11 | N/A |
6/30/2021 | 6 | -39 | -79 | -79 | N/A |
3/31/2021 | 7 | -70 | -88 | -88 | N/A |
12/31/2020 | 9 | -101 | -97 | -96 | N/A |
9/30/2020 | 24 | -84 | -73 | -71 | N/A |
6/30/2020 | 39 | -67 | -49 | -46 | N/A |
3/31/2020 | 39 | -66 | -49 | -47 | N/A |
12/31/2019 | 39 | -65 | -50 | -48 | N/A |
9/30/2019 | 23 | -80 | -62 | -60 | N/A |
6/30/2019 | 8 | -94 | -73 | -71 | N/A |
3/31/2019 | 8 | -87 | -66 | -64 | N/A |
12/31/2018 | 7 | -80 | -59 | -56 | N/A |
9/30/2018 | 7 | -75 | N/A | N/A | N/A |
6/30/2018 | 7 | -70 | -58 | -56 | N/A |
3/31/2018 | 7 | -63 | -55 | -53 | N/A |
12/31/2017 | 7 | -56 | -53 | -50 | N/A |
9/30/2017 | 7 | -50 | N/A | N/A | N/A |
6/30/2017 | 8 | -44 | -42 | -40 | N/A |
3/31/2017 | 7 | -39 | N/A | -34 | N/A |
12/31/2016 | 7 | -34 | N/A | -27 | N/A |
9/30/2016 | 6 | -27 | N/A | -23 | N/A |
6/30/2016 | 5 | -21 | N/A | -18 | N/A |
3/31/2016 | 5 | -19 | N/A | -16 | N/A |
12/31/2015 | 4 | -17 | N/A | -15 | N/A |
9/30/2015 | 5 | -17 | N/A | -17 | N/A |
6/30/2015 | 5 | -17 | N/A | -19 | N/A |
3/31/2015 | 6 | -17 | N/A | -17 | N/A |
12/31/2014 | 7 | -17 | N/A | -15 | N/A |
9/30/2014 | 7 | -15 | N/A | -15 | N/A |
6/30/2014 | 7 | -14 | N/A | -14 | N/A |
3/31/2014 | 6 | -13 | N/A | -11 | N/A |
12/31/2013 | 6 | -13 | N/A | -9 | N/A |
9/30/2013 | 6 | -11 | N/A | -8 | N/A |
6/30/2013 | 6 | -9 | N/A | -7 | N/A |
3/31/2013 | 6 | -7 | N/A | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XUPB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.6%).
Earnings vs Market: XUPB is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: XUPB is expected to become profitable in the next 3 years.
Revenue vs Market: XUPB's revenue (23.8% per year) is forecast to grow faster than the German market (5% per year).
High Growth Revenue: XUPB's revenue (23.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if XUPB's Return on Equity is forecast to be high in 3 years time